Your shopping cart is currently empty

Astin C (Asterin), a naturally occurring cyclic peptide that can be extracted from Aster tataricus, specifically blocks IRF3 recruitment at the STING signalosome inhibiting cGAS-STING signaling and innate inflammatory responses triggered by cytoplasmic dna, resulting in mice that are more susceptible to HSV-1 infection and significantly attenuating autoinflammatory responses.


| Description | Astin C (Asterin), a naturally occurring cyclic peptide that can be extracted from Aster tataricus, specifically blocks IRF3 recruitment at the STING signalosome inhibiting cGAS-STING signaling and innate inflammatory responses triggered by cytoplasmic dna, resulting in mice that are more susceptible to HSV-1 infection and significantly attenuating autoinflammatory responses. |
| Targets&IC50 | Ifnb and Cxcl10 expression (IMR-90 cells via STING pathway):10.8 μM, Ifnb and Cxcl10 expression (MEFs via STING pathway):3.4 μM |
| In vitro | Astin C (10 μM, 6 h) inhibited the expression of DNA- or HSV-1–induced genes such as Ifnb and Cxcl10 in MEFs and IMR-90 cells, with IC₅₀ values of 3.4 μM and 10.8 μM respectively, indicating it is a STING pathway inhibitorp[1]. |
| In vivo | In Trex1⁻/⁻ mice, Astin C (1 mg/kg, i.v., every other day for 14 days) reduced inflammatory gene expression across multiple tissues, alleviated autoimmune-related pathology, and decreased activated CD8⁺ T cells, showing anti-inflammatory and immunoregulatory effects[1]. |
| Synonyms | Asterin |
| Molecular Weight | 570.47 |
| Formula | C25H33Cl2N5O6 |
| Cas No. | 148057-23-2 |
| Smiles | O=C1NC(C(=O)N2CC(Cl)C(Cl)C2C(=O)NC(C(=O)NC(C(=O)NC(C=3C=CC=CC3)C1)CO)CC)CC |
| Relative Density. | 1.46g/cm3 |
| Sequence | Cyclo({Abu}-Pro-{Abu}-Ser-{Oaa}) |
| Sequence Short | Cyclo({Abu}-P-{Abu}-S-{Oaa}) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (140.24 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.